# Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

> **NCT05932719** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 4000 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Peritoneal Carcinoma

## Interventions

- **OTHER:** COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

## Key facts

- **NCT ID:** NCT05932719
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2023-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932719, "Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05932719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*